Health Care: Drugs

ACADIA Pharmaceuticals Inc (ACAD: NASDAQ)

$34.83 n/a | n/a%
03/24/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 17.33M 61.00K 120.00K 1.15M
Cost of Sales 1.16M 0.00 0.00 0.00
Gross Operating Profit 16.17M 61.00K 120.00K 1.15M
Selling, General, and Administrative Expenses 187.79M 90.80M 32.75M 12.72M
Research & Development 99.28M 73.87M 60.60M 26.72M
Operating Income before D & A (EBITDA) -270.90M -164.61M -93.23M -38.30M
Depreciation & Amortization 1.92M -1.41M 690.00K 1.61M
Interest Income 2.76M 499.00K 755.00K 349.00K
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -270.05M -162.70M -93.17M -39.55M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -270.05M -162.70M -93.17M -39.55M
Income Taxes 1.34M 330.00K 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -271.39M -164.44M -92.47M -37.95M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -271.39M -164.44M -92.47M -37.95M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -271.39M -164.44M -92.47M -37.95M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-271.39M -164.44M -92.47M -37.95M
Preferred Dividends
Net Income Available To Common -271.39M -164.44M -92.47M -37.95M
Basic EPS from Continuing Ops. -2.34 -1.63 -0.95 -0.44
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -2.34 -1.63 -0.95 -0.44
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -2.34 -1.63 -0.95 -0.44
Basic Normalized Net Income/Share -2.34 -1.63 -0.95 -0.44
EPS fr Continuing Ops. -2.34 -1.63 -0.95 -0.44
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -2.34 -1.63 -0.95 -0.44
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -2.34 -1.63 -0.95 -0.44
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-2.34 -1.63 -0.95 -0.44
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ACAD

Latest ACAD Headlines from TheStreet

More Financial News for ACAD

Press Releases for ACAD

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter